A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The Phase III trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback